All In MedTech

Device Trial Radar · NCT04793893

Treatment of Residual Hypermetropic Refraction on Young Patients After LASIK Using Human Fresh Corneal Lenticule Implantation With ReLEX Smile Surgery

Treatment of Residual Hypermetropic Refraction on Young Patients After LASIK Using Human Fresh Corneal Lenticule Implantation Using Relex Smile Surgery

Last checked: Nov 20, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

42

Actual

Start

Jan 8, 2017

Primary completion

Jan 8, 2018

Study completion Sep 8, 2027

Sponsor

Lead sponsor
Eye Hospital Pristina KosovoAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 11, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 20 years, up to 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

LASIK (laser-assisted in situ keratomileusis) is a type of refractive surgery for correction of myopia, hyperopia and astigmatism. Yet approximately 30% of operated patients have symptoms like glare, halos, dry eyes and especially residual hypermetrop refractive errors. Residual hypermetrop refractive errors are difficult to treat surgically, the current treatment is Refractive Lens Implantation - risks are similar to those of cataract surgery (endophthalmitis, loss of accommodation, etc.)

Conditions

  • Refractive Errors

Interventions

  • ReLex SmileDevice

    With the ReLex Smile the optical zone (lenticule diameter) and cap diameter are 6.5 and 7.5 mm respectively. After dissection of both anterior and posterior planes, the lenticule is extracted through 120 degree superior 3.5 mm incision and marked with a sterile marker (ViscotMedster). This retrospective case series included 84 eyes of 42 patients (15 male, 27 female; mean age 32.9 ± 7.5 years, range 22-44 years) who underwent positive meniscus-shaped lenticule transplantation for correction of residual hyperopia and presbyopia following prior hyperopic LASIK between January 2017 and December 2018. Of these, 13 patients (31.0%) were aged ≥40 years with established presbyopia. Preoperative refractive error was +3.68 ± 1.32 D (range +1.00 to +6.00 D) with a mean cylinder of +1.36 ± 0.43 D (range +0.75 to +2.00 D). Mean preoperative central corneal thickness was 493.87 ± 34.04 µm (range 440-560 µm).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Increase of visual acuityTime frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Eye Hospital Pristina

    Pristina, Kosovo

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.